Investor Relations. Akari Therapeutics, plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.
... AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the company will present new pre ...
Find the latest Akari Therapeutics plc ADS (AKTX) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq.com.
Akari Therapeutics, Plc - Depositary Receipt (Common Stock) (US:AKTX) has 17 institutional owners and shareholders that have filed 13D/G or 13F forms with ...
“Samir is a long-time investor in Akari and brings to us broad life sciences experience and a track record of multiple successful startup companies. I am ...
Akari Therapeutics (AKTX) financials statements overview reports - Akari Therapeutics's market cap is currently ―. The company's EPS TTM is ―; its P/E ratio ...
Akari Therapeutics PLC ADR balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View AKTX financial statements in full.
Missing: relations | Show results with:relations
AKTX SEC Filings - Akari Therapeutics, Plc - Depositary Receipt (Common Stock)- Annual Report, Proxy Statement, Prospectus. ... investor presentations (found in ...
Find the latest Akari Therapeutics, Plc (AKTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
A high-level overview of Akari Therapeutics, Plc (AKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and ...
Missing: relations | Show results with:relations